Increased heterogeneity of chromosome 17 aneuploidy in endometriosis

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 4, 1999, Pages 792-797

  Kosugi, Yoshinori ^b   Elias, Sherman ^b   Malinak, L Russell ^b   Nagata, Junko ^b   Isaka, Keiichi ^b   Takayama, Masaomi ^b   Simpson, Joe Leigh ^b   Bischoff, Farideh Z ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Aneuploidy; Endometriosis; Fluorescence in situ hybridization; Heterogeneity

Indexed keywords

ANEUPLOIDY; CELLULAR DISTRIBUTION; CHROMOSOME 17; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOSS; GENE MUTATION; GENETIC HETEROGENEITY; GENOME; HUMAN; HUMAN CELL; MYOMETRIUM; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

EID: 0032901315     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70649-6     Document Type: Conference Paper

References (18)

1. 1. Simpson JL, Elias S, Malinak LR, Buttram VC. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980;137:327-31.
2. 2. Moen NH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand 1993;72:560-4.
3. 3. Moen NH. Endometriosis in monozygotic twins. Acta Obstet Gynecol Scand 1994;73:59-62.
4. 4. Tischfield JA. Loss of heterozygosity. Am J Hum Genet 1997;61:995-9.
5. 5. Jones MH, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer 1994;9:119-23.
6. 6. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997;150:177-85.
7. 7. Kihana T, Hamada K, Inoue Y, Yano N, Iketani H, Murao S-I, et al. Mutation and allelic loss of the p53 gene endometrial carcinoma. Cancer 1995;76:72.
8. 8. Honda T, Kato H, Imamura T, Gima T, Nishida J, Sasaki M, et al. Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer 1993;53:963.
9. 9. McManus DT, Yap EPH, Maxwell P, Russell SEH, Toner PG, McGee JOD. p53 expression, mutation, and allelic deletion in ovarian cancer. J Pathol 1994;174:159-68.
10. 10. Jimbo H, Yoshikawa H, Onda T, Yasugi T, Sakamoto A, Taketani Y. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynaecol Obstet 1997;59:215-50.
11. 11. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its dose association with malignant epithelial tumours. Histopathology 1997;30:249-55.
12. 12. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 1996;56:3534-9.
13. 13. Anderson LA, Friedman L, Osborne-Lawrence S, Lynch E, Weeissenbach J, Bowcock A, et al. High-density genetic map of the BRCA1 region of chromosome 17q12-21. Genomics 1993;17:618-32.
14. 14. Osborne RJ, Leech VL. PCR allelotyping of human ovarian cancer. Br J Cancer 1994;69:429-38.
15. 15. Shin JC, Ross HL, Elias S, Nguyen DD, Mitchell-Leef D, Simpson JL, et al. Detection of chromosomal aneuploidy in endometriosis by multicolor fluorescence in situ hybridization (FISH). Hum Genet 1997;100:401-6.
16. 16. Simpson JL, Malinak LR, Elias S, Carson SA, Radvany RA. HLA association in endometriosis. Am J Obstet Gynecol 1984;148:395-7.
17. 17. Moen M, Bratlie A, Moen T. Distribution of HLA-antigens among patients with endometriosis. Acta Obstet Gynecol Scand Suppl 1984;123:25-7.
18. 18. Hedrick L. Endometrial cancer. In: Vogelstein B, Kinzler K, editors. The genetic basis of human cancer. New York: McGraw-Hill; 1997. p. 621-9.